Free Biopharma Stock Content

$XBI $122.47 -2.1% Covid Updates $BNTX +5.4% New Formulation of COMIRNATY® Receives Positive Opinion from CHMP. source $DVAX +1.2%...

$XBI $125.08 -1.5% Covid Updates $PFE -0.5% Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age...

$XBI $127.10 +1.67% Covid Updates $MRNA +3.2% Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use...

$XBI $125.01 +0.32% Pipeline Updates $SRNE +2.3% Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2...

$XBI $124.61 +0.44% Covid Updates $MRNA +2.0% Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of...

Summary Upcoming biopharma conferences that will release abstracts in October 2021 include the Consortium of Multiple Sclerosis Centers...

$XBI $124.07 +0.5% Covid Updates $AZN +0.3% AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient...

$XBI $123.44 Pipeline Updates $FBIO Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper...

$XBI $123.91 +1.32 Covid Updates $VXRT -0.14% New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces...

$XBI $122.29 -1.06% Covid Updates $ENTA +1.1% NEW PRECLINICAL DATA FOR EDP-235, ENANTA’S ORAL PROTEASE INHIBITOR SPECIFICALLY DESIGNED...

$XBI $123.60 +0.31% Covid Updates $MRNA +1.9% Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine...

$XBI $123.22 -2.3% Covid Updates $BNTX -2.3% Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the...

$XBI $126 +0.5% Pipeline Updates $MCRB +4% SERES THERAPEUTICS PRESENTS LATE-BREAKING DATA FROM SER-109 PHASE 3 ECOSPOR III STUDY IN...

$XBI $125.71 +0.06% Covid Updates $TRVN +0.8% Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients source...

$XBI $125.63 -1.7% Covid Updates $VBIV -4.3% VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study...

Summary The Liver Meeting is a yearly conference that is the premier meeting on liver disease and cutting-edge science This meeting...

$XBI $127.74 -3.16% Covid Updates $HGEN -3.6% Humanigen Announces the European Medicines Agency Has Appointed a Rapporteur and ...

$XBI $131.91 +1.50% Covid Updates $NRXP +6.8% NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19...

$XBI $130.37 -2.03% Pipeline Updates $OPK -3.4% Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application...

$XBI $133.07 +1.88% Pipeline Updates $VTVT +19.2% vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development...